Evoke Pharma, Inc.
EVOK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13,597 | $4,739 | $9,844 | $9,145 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2,420 | $673 | $625 | $295 |
| Inventory | $445 | $482 | $289 | $186 |
| Other Curr. Assets | $776 | $933 | $965 | $935 |
| Total Curr. Assets | $17,238 | $6,827 | $11,722 | $10,561 |
| Property Plant & Equip (Net) | $154 | $0 | $129 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $127 | $242 | $0 | $0 |
| Total NC Assets | $281 | $242 | $129 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $17,519 | $7,069 | $11,851 | $10,573 |
| Liabilities | – | – | – | – |
| Payables | $2,041 | $1,712 | $868 | $874 |
| Short-Term Debt | $5,060 | $5,000 | $129 | $12 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,279 | $2,936 | $657 | $519 |
| Total Curr. Liab. | $10,380 | $9,648 | $1,655 | $1,406 |
| LT Debt | $101 | $5,000 | $5,000 | $5,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | -$5,000 | $1,112 | $612 |
| Total NC Liab. | $101 | $0 | $6,112 | $5,612 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $160 | $0 | $129 | $12 |
| Total Liabilities | $10,481 | $9,648 | $7,767 | $7,018 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$128,792 | -$123,439 | -$115,647 | -$107,423 |
| AOCI | -$0 | $0 | $0 | $0 |
| Other Equity | $135,829 | $120,860 | $119,731 | $110,978 |
| Total Equity | $7,038 | -$2,580 | $4,085 | $3,555 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $17,519 | $7,069 | $11,851 | $10,573 |
| Net Debt | -$8,436 | $5,261 | -$4,715 | -$4,132 |